Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Comment by MoneyMouthon May 19, 2022 3:17pm
189 Views
Post# 34696223

RE:RE:RE:RE:RE:1.55 LOL Next stop, 1.40?

RE:RE:RE:RE:RE:1.55 LOL Next stop, 1.40?It should have affected the share price. I mean this deal outlines Evotecs valuation of the company and that valuation should mean something to investors. Evotecs average price per share here is ~$1.85 (after the investement in august). In the case of Sernova, the share price is only affected by the few people who actually trade this stock (looking at you Bio) while all of the longs sit and watch on the sidelines. And its frustrating for long term shareholders because we watch as a measly 1 million shares traded sets the value of the other  300 million+ shares. The share price for this company is not indicitive of anything except a few penny flippers having fun trading trends. All of the longs are holding, while the flippers are flipping and saying screw fundamentals, screw value, I'm selling now because News = Sell and that's the trend. Bio, how many shares did you trade on monday? I'm curious to see how much you played a part in mondays million share downturn. 
<< Previous
Bullboard Posts
Next >>